Reversing pancreatic β-cell dedifferentiation in the treatment of type 2 diabetes

J Son, D Accili - Experimental & Molecular Medicine, 2023 - nature.com
The maintenance of glucose homeostasis is fundamental for survival and health. Diabetes
develops when glucose homeostasis fails. Type 2 diabetes (T2D) is characterized by insulin …

DYRK1A inhibitors for disease therapy: Current status and perspectives

T Liu, Y Wang, J Wang, C Ren, H Chen… - European journal of …, 2022 - Elsevier
Dual-specificity tyrosine phosphorylation-regulated kinase 1 A (DYRK1A) is a conserved
protein kinase that plays essential roles in various biological processes. It is located in the …

Dual-specificity, tyrosine phosphorylation-regulated kinases (DYRKs) and cdc2-like kinases (CLKs) in human disease, an overview

MF Lindberg, L Meijer - International Journal of Molecular Sciences, 2021 - mdpi.com
Dual-specificity tyrosine phosphorylation-regulated kinases (DYRK1A, 1B, 2-4) and cdc2-
like kinases (CLK1-4) belong to the CMGC group of serine/threonine kinases. These protein …

The human islet: mini-organ with mega-impact

JT Walker, DC Saunders, M Brissova… - Endocrine …, 2021 - academic.oup.com
This review focuses on the human pancreatic islet—including its structure, cell composition,
development, function, and dysfunction. After providing a historical timeline of key …

DYRK1A inhibitors as potential therapeutics for β-cell regeneration for diabetes

K Kumar, C Suebsuwong, P Wang… - Journal of Medicinal …, 2021 - ACS Publications
According to the World Health Organization (WHO), 422 million people are suffering from
diabetes worldwide. Current diabetes therapies are focused on optimizing blood glucose …

Genetic and pharmacologic inhibition of ALDH1A3 as a treatment of β-cell failure

J Son, W Du, M Esposito, K Shariati, H Ding… - Nature …, 2023 - nature.com
Abstract Type 2 diabetes (T2D) is associated with β-cell dedifferentiation. Aldehyde
dehydrogenase 1 isoform A3 (ALHD1A3) is a marker of β-cell dedifferentiation and …

Single-nucleus RNA sequencing of human pancreatic islets identifies novel gene sets and distinguishes β-cell subpopulations with dynamic transcriptome profiles

RB Kang, Y Li, C Rosselot, T Zhang, M Siddiq… - Genome Medicine, 2023 - Springer
Background Single-cell RNA sequencing (scRNA-seq) provides valuable insights into
human islet cell types and their corresponding stable gene expression profiles. However …

Disrupting the DREAM complex enables proliferation of adult human pancreatic β cells

P Wang, E Karakose, C Argmann… - The Journal of …, 2022 - Am Soc Clin Investig
Resistance to regeneration of insulin-producing pancreatic β cells is a fundamental
challenge for type 1 and type 2 diabetes. Recently, small molecule inhibitors of the kinase …

E2F1 transcription factor mediates a link between fat and islets to promote β cell proliferation in response to acute insulin resistance

J Shirakawa, Y Togashi, G Basile, T Okuyama, R Inoue… - Cell reports, 2022 - cell.com
Prevention or amelioration of declining β cell mass is a potential strategy to cure diabetes.
Here, we report the pathways utilized by β cells to robustly replicate in response to acute …

[HTML][HTML] Emerging diabetes therapies: Bringing back the β-cells

G Basile, MMF Qadir, F Mauvais-Jarvis, A Vetere… - Molecular …, 2022 - Elsevier
Background Stem cell therapies are finally coming of age as a viable alternative to
pancreatic islet transplantation for the treatment of insulin-dependent diabetes. Several …